Free Trial
OTCMKTS:TRUMY

Terumo (TRUMY) Stock Price, News & Analysis

Terumo logo
$15.05 0.00 (0.00%)
As of 11/13/2026 03:55 PM Eastern

About Terumo Stock (OTCMKTS:TRUMY)

Advanced

Key Stats

Today's Range
$14.94
▼
$15.08
50-Day Range
$13.25
▼
$16.43
52-Week Range
$12.08
▼
$16.81
Volume
462,979 shs
Average Volume
173,876 shs
Market Capitalization
$22.20 billion
P/E Ratio
31.35
Dividend Yield
0.40%
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Terumo Corporation is a Japan-based medical technology company that develops and manufactures products for hospitals, clinics and other healthcare providers. Founded in 1921, the company began by producing clinical thermometers and has since expanded into a broad range of medical devices and services.

Terumo’s businesses include cardiovascular and vascular products, such as catheter-based devices and systems used in the treatment of heart and vascular conditions; medical care products, including infusion and injection devices; and blood and cell technologies used to collect, process and manage blood and cellular therapies.

Headquartered in Tokyo, Terumo serves healthcare customers in Japan and markets around the world. Its products support areas including patient care, cardiovascular treatment, transfusion medicine and cell therapy.

AI Generated. May Contain Errors.

Terumo Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

TRUMY MarketRank™: 
0.330677290835 of 5 stars

Terumo scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Terumo are expected to decrease by -6.98% in the coming year, from $0.86 to $0.80 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Terumo is 31.35, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.39.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Terumo is 31.35, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.59.

  • Price to Book Value per Share Ratio

    Terumo has a P/B Ratio of 2.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.00% of the float of Terumo has been sold short.
  • Short Interest Ratio / Days to Cover

    Terumo has a short interest ratio ("days to cover") of 0.13, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Terumo has recently increased by 150.52%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Terumo has a dividend yield of 0.37%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Terumo does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Terumo is 12.50%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Terumo will have a dividend payout ratio of 7.50% next year. This indicates that Terumo will be able to sustain or increase its dividend.

  • Read more about Terumo's dividend.
  • News Sentiment

    Terumo has a news sentiment score of -0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Terumo this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Terumo insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Terumo has minimal institutional ownership at this time.

  • Read more about Terumo's insider trading history.
Receive TRUMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Terumo and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TRUMY Stock News Headlines

Terumo (OTCMKTS:TRUMY) Shares Gap Down Following Weak Earnings
Executive Order 14241 Unleashes Trump’s New Dollar
A landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December. The agenda at the upcoming G20 Summit in Miami has shifted, and new research points to a major monetary announcement from President Trump. A new documentary breaks down what this shift could mean for savings, investments, and the assets tied to it.tc pixel
Terumo (OTCMKTS:TRUMY) Stock Falls 7.4% Following Weak Earnings
Terumo Corporation (TRUMY) Q2 2027 Earnings Call Transcript
Terumo ADR (TRUMY) Ratios
Terumo ADR (TRUMY)
See More Headlines

TRUMY Stock Analysis - Frequently Asked Questions

Terumo's stock was trading at $14.49 at the start of the year. Since then, TRUMY shares have increased by 3.9% and is now trading at $15.05.

Terumo Corp. (OTCMKTS:TRUMY) released its quarterly earnings data on Thursday, November, 12th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of ($0.01) by $0.06. The business had revenue of $1.96 billion for the quarter, compared to analyst estimates of $1.94 billion. Terumo had a net margin of 9.31% and a trailing twelve-month return on equity of 7.03%.

Shares of Terumo split on the morning of Thursday, March 28th 2024.The 2-1 split was announced on Thursday, March 28th 2024. The newly created shares were payable to shareholders after the closing bell on Thursday, March 28th 2024. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Shares of TRUMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/12/2026
Today
11/15/2026
Fiscal Year End
3/31/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:TRUMY
Previous Symbol
NASDAQ:TRUMY
CIK
1446672
Employees
30,000
Year Founded
1964

Profitability

EPS (Trailing Twelve Months)
$0.48
Trailing P/E Ratio
31.35
Forward P/E Ratio
18.81
P/E Growth
N/A
Net Income
$897.03 million
Net Margins
9.31%
Pretax Margin
15.75%
Return on Equity
7.03%
Return on Assets
4.83%

Debt

Debt-to-Equity Ratio
0.13
Current Ratio
2.19
Quick Ratio
1.37

Sales & Book Value

Annual Sales
$7.52 billion
Price / Sales
2.95
Cash Flow
$1.04 per share
Price / Cash Flow
14.49
Book Value
$7.09 per share
Price / Book
2.12

Miscellaneous

Outstanding Shares
1,475,070,000
Free Float
N/A
Market Cap
$22.20 billion
Optionable
Not Optionable
Beta
0.82

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (OTCMKTS:TRUMY) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners